Bicycle Therapeutics’ (BCYC) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a report published on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a $30.00 target price on the stock. A number of other research firms have also commented on BCYC. JMP Securities reduced their price target […]
Needham & Company LLC restated their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a report published on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a $30.00 target price on the stock. A number of other research firms have also commented on BCYC. JMP Securities reduced their price target […]